TG Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF87.97 | CHF105.00 | 22.34% | 9 | CHF179.49B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $89.17B |
| MRK | Merck KGaA | Outperform |
18
|
152.00€ | 190.06€ | 20.39% | 4 | 66.09€B |
| BIIB | Biogen | Outperform |
10
|
$217.51 | $299.62 | 32.64% | 13 | $31.67B |
| BAYN | Bayer | Hold |
5
|
28.02€ | 45.15€ | 7.07% | 4 | 27.53€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.06k | kr2.71k | 28.09% | 14 | kr133.28B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| ALKS | Alkermes | Outperform |
10
|
$24.05 | $33.27 | 33.06% | 3 | $4.06B |